Finecure offering Niche Products In Chronic Category As Business Strategy

Finecure offering Niche Products In Chronic Category As Business Strategy

We at Finecure have shown a keenness to address the ever increasing numbers of lifestyle diseases like Diabetes, Hypertension and Cardiovascular diseases. The demand for medicines used in these chronic illnesses is growing rapidly and supplies are not managing to keep pace with the demand. The trend is likely to sustain, given the increased incidence of chronic lifestyle disorders in a steadily prospering economy. For instance, India is estimated to soon overtake China to become the world’s diabetes capital. Acute therapy medicines are normally used for a shorter duration whereas medicines for chronic medicines are often used for the entire lifetime of a patient. Anti-invectives, a category of medicines used to treat infections (primarily antibiotics), pain and acidity, are in the acute segment whereas those in the chronic category are used for long-term treatments like diabetes, high blood pressure and lipid-lowering drugs are classified into the chronic category. The fact that chronic therapies are need to be addressed to help fill a vacuum due to cost that had made these medicines inaccessible to the common man. Finecure is focusing on many brands with focus on chronic care for Cardiovascular, Diabetes, Gastroenterology, and supplements. Today Finecure has become a significant player in the chronic therapy areas of Diabetes, Blood Pressure and Cardiac diseases. Finecure offers high-quality yet affordable medicines for some of the most chronic diseases addressing unmet needs in many parts of the world.